Harvard's New Place | GenomeWeb

Harvard's New Place

Harvard has revamped its proposal for a new science campus in Allston to include an "enterprise research campus" with as many as 12 buildings for pharmaceutical, biotechnology, and venture capital companies, alongside the planned 700,000 square feet of space for labs and academic researchers, report the Boston Globe's Liz Kowalczyk and Megan Woolhouse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.